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The adipocyte is central to organismal metabolism
and exhibits significant functional andmorphological
plasticity during its formation and lifespan. Remark-
able transformations of this cell occur during obesity
and lactation, and thus it is essential to gain a better
understanding of adipocyte function in these two
metabolic processes. Considering the critical impor-
tance of the cellular organelle endoplasmic reticulum
(ER) in adapting to fluctuations in synthetic pro-
cesses, we explored the role of XBP1, a central
regulator of ER adaptive responses, in adipocyte
formation and function. Unexpectedly, deletion of
adipocyte-XBP1 in vivo in mice (XBP1DAd) had no
effect on adipocyte formation or on systemic homeo-
static metabolism in mice fed a a regular or high-fat
diet. However, during lactation, XBP1DAd dams dis-
played increased adiposity, decreased milk pro-
duction, and decreased litter growth as compared
with control dams. Moreover, we demonstrate that
XBP1 is regulated during lactation and responds to
prolactin to alter lipogenic gene expression. These
results demonstrate a role for adipocyte-XBP1 in
the regulation of lactational metabolism.
INTRODUCTION
The fat cell, or adipocyte, is a central regulator of metabolism
that is conserved in organisms ranging from flies to humans.
At the core of the adipocyte’s function is its ability to store and
release lipid in flux with the energy demands of the organism.
As such, the life of the adipocyte encompasses many extreme
fluctuations in lipid storage capacity, beginning with the devel-
opment of a preadipocyte into a mature adipocyte, and then
continuing to respond to metabolic signals. For example, the
adipocyte must deplete its lipid supply under nutrient-scarce
or high-energy-demand states such as starvation or lactation,
or increase its lipid stores under nutrient-rich conditions,
including obesity (Attie and Scherer, 2009).1430 Cell Reports 3, 1430–1439, May 30, 2013 ª2013 The AuthorsIn previous studies we showed that under obese conditions,
adipose tissue function is compromised, possibly due to the
upregulation of inflammatory and/or endoplasmic reticulum
(ER) stress signaling resulting from disruption of the functional
integrity of this organelle and activation of its unfolded protein
response (UPR). Indeed, in both mice and humans the UPR
was activated in adipose tissue in obesity (Hotamisligil, 2010).
One specific molecule identified in these studies was X-box
binding protein 1 (XBP1), a transcription factor that is involved
in the most ancient arm of the UPR. The UPR transmembrane
sensor inositol-requiring enzyme 1a (IRE1a) functions upon
activation as an endoribonuclease to cleave 26 bp from the
messenger RNA (mRNA) of XBP1. This spliced form of XBP1
(sXBP1) encodes an active transcription factor that upregulates
target genes involved in a myriad of ER-related processes,
including protein synthesis, protein folding, ER-associated
degradation, and ER expansion (Ron and Walter, 2007). In
addition to its role in ER stress, XBP1 is known to be essential
for the in vivo differentiation of various secretory cell types,
such as plasma cells and pancreatic and salivary exocrine cells
(Glimcher, 2010). Recently, experimental suppression of XBP1
in preadipocyte cell lines was reported to result in incomplete
adipogenesis in vitro (Basseri et al., 2009; Sha et al., 2009). How-
ever, the role of XBP1 in adipocytes in vivo remains unknown.
Since adipose tissue XBP1 expression is increased in mouse
and human obesity, characterized by robust expansion of
adipose tissue, we set out to interrogate the biology of this
molecule under conditions that represent extremes of adipose
tissue fluctuation (namely, obesity and lactation) in vivo.
We found that, in contrast to expectations, genetic deletion of
adipocyte XBP1 did not affect adipose tissue formation and
function under homeostatic metabolic conditions. However,
we report that XBP1 plays an unanticipated role in regulating
adipose tissue function during the homeorhetic, or directional,
metabolism of lactation.
RESULTS
In Vivo Deletion of Adipocyte XBP1
We began our study by suppressing Xbp1 expression in cultured
adipocytes, and observed an inhibition of differentiation as
reported previously (Figures 1A–1C; Sha et al., 2009). However,
this function of XBP1 was limited in vitro and the inhibitory effect
on adipocyte differentiation could be overcome by stronger
stimuli that promote adipogenesis, such as thiazolidinediones
(Figures 1B and 1C). Therefore, we utilized adipocyte-specific
deletion models of XBP1 to investigate the formation and func-
tion of adipocytes in a physiological context in vivo in mice.
The loxP-Cre system utilizing Cre under the aP2 promoter
efficiently deleted XBP1 in adipose tissue at both the mRNA
and protein levels (Figures 1D and S1A). We next performed
a metabolic characterization of the mice harboring adipocyte
deletion of XBP1 (XBP1DAd). Compared with wild-type (WT)
mice, deletion of adipocyte XBP1 did not affect body weight,
adipose tissue mass, serum insulin, or glucose homeostasis
when the mice were fed a regular chow diet (Figures S1B–
S1G). Interestingly, when animals were challenged with a high-
fat diet (HFD), representing one extreme of adipocyte plasticity
and function, body weight and adiposity were still unaltered
(Figures 1E–1G). In addition, no differences were found in
adipose-tissue morphology, serum insulin, serum adiponectin,
or systemic glucose tolerance between WT and XBP1DAd mice
(Figures 1H–1K). These results indicate that in mice, XBP1 is
not a contributing factor to the formation or expansion of adipose
tissue and, moreover, it does not regulate adipocyte function or
glucose homeostasis under the stress of obesity.
XBP1 Is Regulated during Lactation in Adipocytes
Next, we tested another extreme condition of adipocyte trans-
formation: lactation. Throughout pregnancy, maternal body
weight increases, and after parturition, lactation commences
and adipose-tissue lipid stores are utilized as components of
milk or energy sources for its production. In order to achieve
this partitioning of nutrients, adipocytes undergo a dramatic
transformation involving severe lipid depletion and suppression
of glucose and lipid uptake. Although this phenomenon has
been observed morphologically (Elias et al., 1973), little is known
about the functional role of the adipocyte during lactation or the
molecular mediators that are involved in this process.
To determine the potential relevance of XBP1 to adipocytes
during lactation, we examined the regulation of Xbp1 expression
in vivo in adipose tissue during pregnancy and throughout
lactation. In gonadal adipose tissue, a depot that is devoid of
mammary gland, we observed significant upregulation of total
and spliced forms of Xbp1mRNA during lactation, but not during
pregnancy, corresponding to the time of substantial adipocyte
transformation (Figure 2A). We also observed increased total,
but not spliced, Xbp1mRNA in the inguinal adipose depot, which
develops into mammary gland during lactation (Figure S2A).
In order to explore XBP1 regulation further, we treated cultured
adipocytes with prolactin, the primary lactogenic hormone that
orchestrates milk production (Figures 2B and 2C). Previous
studies identified the prolactin receptor on mouse and human
adipocytes and showed that its expression increases in adipose
tissue during lactation (Flint et al., 2003; Ling et al., 2000). We
found that exposure of adipocytes to prolactin in vitro resulted
in increased total and spliced Xbp1 expression (Figures 2B and
2C), which was similar to the patterns seen in lactating tissues
in vivo. The effect of prolactin in adipocytes also revealed no
changes or mild increases in other UPR markers. These resultsCwarrant further investigation into the role of the UPR in adipo-
cytes during lactation and may suggest a potentially distinctive
role for adipocyte XBP1.
Loss of Adipocyte XBP1 Disturbs Lactational
Metabolism
Interestingly, we observed that when XBP1DAd dams underwent
lactation, they displayed an increase in adiposity compared with
WT controls (Figures 2D and 2E). Under normal conditions, the
metabolic characteristics of female XBP1DAd mice, such as
body weight, adipose tissue weight, blood glucose, and serum
insulin and lipid levels, were similar to those of the WT controls
(Table S1). In addition, during pregnancy, no significant differ-
ences were observed between WT and XBP1DAd dams in terms
of body weight, blood glucose and insulin levels, litter weights
upon delivery, or number of pups per litter (Figures S2B–S2F).
Food intake during pregnancy and lactation was also similar
between WT and XBP1DAd dams (Figures S2G and S2H).
However, during lactation, adipose tissue mass was signifi-
cantly increased in the XBP1DAd dams but remained low in the
WT dams compared with nonpregnant (NonPG) mice (Figures
2D and 2E). We also observed elevated serum insulin and
leptin levels, and a trend toward increased total body weight in
XBP1DAd dams, again indicating higher adiposity (Figures 2F
and S2I). Strikingly, litters from XBP1DAd dams gained less
weight during lactation than those from WT dams (Figure 2G).
Therefore, we thought it critical to examine whether the maternal
or fetal genotype was the driver of this phenotype and whether
WT dams could rescue this effect. For this purpose, we per-
formed cross-fostering experiments. Nursing of XBP1DAd pups
by WT dams completely rescued the pup phenotype and,
conversely, WT pups nursed by XBP1DAd dams showed a sig-
nificant decrease in body weight during lactation (Figure 2H).
These experiments demonstrated that the effect on pup weight
resulted from the mother’s genotype during lactation and was
not the result of an in utero effect. Taken together, these results
indicate that lactating XBP1DAd dams harbor increased adipose
tissue lipid stores, and insufficient nutrients reach the pups
during lactation.
XBP1 Contribution to Lactation Performance
is Adipocyte Specific
Because the participation of adipocytes in the metabolic transi-
tion of lactation was an unexpected finding, it was critical to
ensure that the observed effects arose from adipocyte XBP1
deficiency per se. Inguinal adipocytes are in close proximity to
the mammary gland during lactation because they share the
same depot. In contrast, visceral and gonadal adipose tissues
do not contain any mammary gland. To verify the specificity of
the adipocyte deletion in the loxP-Cre model, we first performed
fractionation of mammary tissue from days 1 and 10 of lactation
(d1L and d10L, respectively). Figure 3A reveals that Xbp1 is
dramatically deleted in the floating adipocytes of the XBP1DAd
tissues compared with the stromal-vascular fractions. Second,
we performed laser capture microdissection (LCM) of mammary
alveoli from d1L tissues and demonstrated that no deletion of
Xbp1 occurred in the captured cells (Figure 3B), indicating again






















Figure 1. Targeted Deletion of XBP1 in the Adipocyte Does Not Affect Tissue Formation or Function in Homeostatic Metabolism
(A–C) Lentiviral suppression of XBP1 mRNA in 3T3L1 preadipocytes.
(A) Xbp1mRNA levels weremeasured by real-time qRT-PCR. Preadipocytes carrying control or XBP1 shRNA (iXBP1) were induced to differentiate with or without
rosiglitazone (10 mM).
(B and C) On day 8 of differentiation, mRNA levels of the Adiponectin gene were measured by qPCR (B) and bright-phase microscopy images were taken (C).
(D) XBP1 protein levels in fat explants from WT and XBP1DAd mice after treatment with or without protease inhibitor MG132 (25 mM) for 20 hr to stabilize XBP1
protein. Protein extracts were probed using XBP1 or Actin antibody (Santa Cruz). *denotes a nonspecific band.
(E–K) Analyses were performed with male mice (n = 7–12) on HFD.
(E) Body weight of WT and XBP1DAd mice over time on HFD.
(F and G) Percent fat (F) and lean mass and fat mass (G) of WT and XBP1DAd mice (n = 5–11) as measured by dual energy X-ray absorptiometry (DEXA)
analysis.
(legend continued on next page)
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Since regulation of lactation through adipocyte XBP1 is a central
tenant of our observations, we also performed additional genetic
experiments to validate the adipocyte specificity of the effects of
XBP1. First, we examined a potential contribution from macro-
phages because the aP2 promoter can drive gene expression
in these cells (Makowski et al., 2001). For this purpose, we tested
the effects of a macrophage-specific deletion of XBP1 in our
model using the LysM-driven Cre to delete XBP1 in the myeloid
lineage. Loss of macrophage XBP1 did not affect pup growth
during lactation, ruling out a contribution of these cells to the
phenotype (Figure 3C). Next, we utilized a second, independent
adipocyte-specific XBP1-deletion model with Cre expression
driven by the Adiponectin promoter (Eguchi et al., 2011). Impor-
tantly, litters from these XBP1DAd dams also displayed sig-
nificantly decreased growth during lactation compared with the
litters of WT dams (Figure 3D).
We next examined WT and XBP1DAd mammary glands for
morphological or developmental differences. In virgin mice, we
observed slightly reduced mammary gland branching postpu-
berty in XBP1DAd glands compared with WT. However, when
mammary epithelia from XBP1DAd glands were isolated and
transplanted into a WT recipient fat pad, mammary gland
branching was indistinguishable between the genotypes (Fig-
ures S3A and S3B), indicating again that it is the XBP1-deleted
adipose tissue in our model that influences the mammary gland
environment.
Next, we analyzed tissue weights and used a whole-mount
staining technique to visualize the development of the mammary
epithelia and alveoli during lactation. In these experiments, we
did not observe any differences in tissue weight, morphology,
or extent of development in the XBP1DAd glands compared
with WT controls (Figures 3E and 3F). Cross-sections of the
tissues stained by H&E also showed similar mammary develop-
ment in the WT and XBP1DAd tissues (Figure S3C). We also did
not observe any large cytoplasmic lipid droplets apparent in
the alveolar epithelium, which would indicate a secretory defect.
Finally, as a marker of prolactin action, we measured Stat5
signaling in lactating mammary gland tissues from WT and
XBP1DAd mice, and observed no significant differences between
the genotypes (Figures S3D and S3E). Hence, the data obtained
thus far suggest normal mammary gland function in XBP1DAd
dams.
In sum, the results obtained from examination of tissues,
ex vivo investigations, and multiple independent, tissue-specific
deletion models in vivo demonstrate that XBP1 deletion in
the adipocyte is the causative manipulation that produces
a disturbed lactational metabolism.
Analysis of Milk Composition and Quantity in XBP1DAd
Dams
Since adipose tissue lipids are partitioned to themammary gland
during lactation, it was possible that the gonadal accumulation(H) H&E staining of adipose tissue sections from WT and XBP1DAd mice (magni
adipose tissue.
(I and J) Serum insulin (I) and adiponectin (J) levels in WT and XBP1DAd mice (n =
(K) Glucose tolerance test performed after 16 weeks on HFD with (1.0 g/kg gluco
All error bars indicate ±SEM. See also Figure S1.
Cof lipid in XBP1DAd dams would affect milk composition. We
performed a lipidomic analysis of the major lipid classes and
fatty acid composition of those classes in milk produced from
each genotype. No significant differences were found among
the studied lipid classes in XBP1DAd milk compared with WT
(Figures 4A, 4B, and S4A). Additionally, fatty acid composition
was not altered in XBP1DAd milk (Figure 4C) and cluster analysis
did not indicate inherent differences even when the whole data
set was incorporated into the comparisons (Figure S4B). We
also measured lactose and total protein levels in XBP1DAd milk
and found that they were similar to those in WT milk (Figures
4D and 4E). Silver staining of milk proteins also did not reveal
any gross differences (Figure S4C). Therefore, all of the major
components tested showed no effect on milk composition in
XBP1DAd dams that would support a content-related defect.
Hence, we moved on to test whether the amount of milk pro-
duced was affected by adipocyte deletion of XBP1. Indeed,
when we measured milk quantity in pups before and after
controlled feeding, we found that the XBP1DAd dams produced
significantly decreased amounts of milk compared with WT con-
trols (Figure 4F). This reduction in milk production was unlikely to
result from a lack of sufficient prolactin release upon suckling,
since serum prolactin levels in the lactating dams were not
different between genotypes (Figure 4G). Decreased milk
volume can be associated with a reduction in mammary gland
lipogenesis (Boxer et al., 2006). Therefore, we examined lipo-
genic enzymes in lactatingmammary glands ofWT and XBP1DAd
dams. Our analysis revealed no significant differences in the
mRNA levels of the lipogenic genes Fas, Scd1, and Dgat2, and
similar protein levels of FAS, SCD1, ACC, and ACLY in WT and
XBP1DAd dams (Figures S4D and S4E). In addition, wemeasured
phosphorylation of the lipogenic enzymes ACC and ACL to
assess pathway activity and observed no significant differences
between genotypes (Figures S4E and S4F). Hence, with the
measures employed in this study, XBP1DAd mammary gland
lipogenesis appears normal. In sum, although the mechanism
underlying the reduced milk volume in the XBP1DAd dams is
unclear at present, we conclude that adipocyte deletion of
XBP1 does not impact milk composition but results in decreased
milk production during lactation.
XBP1 Regulates the Lipogenic Program in Adipocytes
Although the particular role of the adipocyte during lactation has
not yet been defined, it has long been appreciated that adipose
tissue must moderate lipogenesis and lipid storage activities in
order to direct dietary nutrients to themammary gland to support
milk production. The adipocytes themselves show decreased
lipid uptake and lipogenic activity for the sake of redirecting
nutrients to themilk-producing secretory cells (Bell and Bauman,
1997; Vernon and Pond, 1997). In more specific studies investi-
gating the effects of prolactin on adipocytes, the results have
been inconsistent and often species dependent (Ben-Jonathanfication 1003). EWAT, epididymal white adipose tissue; IWAT, inguinal white
5–6).
se injection, n = 6).







Figure 2. Adipocyte XBP1 Deletion Disturbs Metabolic Flux during Lactation
(A) mRNA levels of Xbp1 in gonadal adipose tissue from WT mice that were NonPG, in late pregnancy (d18PG), or at day 5 (d5L) or 10 (d10L) of lactation.
(B) Fully differentiated adipocytes were treated with or without prolactin for 6 hr and mRNA levels of UPR genes were measured by qPCR.
(C) Both spliced and unspliced forms of XBP1 are shown as PCR products.
(D) Gonadal white adipose tissue (GWAT) wet weights of WT and XBP1DAd dams (NonPG and at d1, d10, and d20L; n = 4–9).
(E) Representative images from CT scans of WT and XBP1DAd dams during peak lactation (d12L). Adipose tissue density is displayed.
(F) Serum insulin and leptin levels of WT and XBP1DAd dams at d20L (n = 3).
(G) Pup weights of litters nursed by WT or XBP1DAd dams during lactation. All litters are mixtures of pup genotypes (WT and XBP1DAd; n = 6–10 litters per
genotype).
(H) Cross-fostering of XBP1DAd and WT litters. Average pup weight during lactation from cross-fostered litters switched on d1L (n = 8–10, litters were pared to
six pups).
All error bars indicate ±SEM. *p < 0.05, **p < 0.01 using standard t test; yp < 0.007 as measured by regular two-way ANOVA. See also Figure S2.




Figure 3. XBP1 Is Deleted Specifically in the Adipocytes of the Mammary Gland
(A) Xbp1 mRNA levels in fractionated mammary tissue from d1L and d10L of lactation. Tissues from WT and XBP1DAd mice were separated into adipocyte and
stromal-vascular (SV) fractions (n = 4–5).
(B) Laser-capture microdissection (LCM) of mammary epithelial cells from mammary glands on d1L. Total RNA was extracted from the microdissected cells to
determine the levels of Xbp1 deletion. Pictures of histology illustrate the area of capture before and after dissection.
(C) Average pup weights of litters nursed by WT and XBP1DMAC (LysM Cre) dams throughout lactation (n = 5–6).
(D) Average pup weights of litters nursed by WT and Adiponectin Cre XBP1DAd dams throughout lactation (n = 5–6).
(E) Mammary gland wet weights of WT and XBP1DAd dams (n = 4–9).
(F) Whole-mount stains of mammary glands from WT and XBP1DAd mice at different stages of mammary development (NonPG, d1L, or d10L).
All error bars indicate ±SEM; *p < 0.05, standard t test. See also Figure S3.et al., 2008). For instance, it is thought that prolactin does not
affect lipolysis in mice. Indeed, when we treated adipose tissue
explants with prolactin, we also did not observe a lipolytic effect
of prolactin, or any differences between WT and XBP1DAd in
terms of lipolytic activity (Figures S4G and S4H). Prolactin has
also been reported to decrease glucose uptake in rodent adipo-
cytes and reduce expression of the lipogenic gene fatty acid syn-Cthase (FAS; Flint et al., 2003; Hogan and Stephens, 2005), hypo-
thetically leading to less lipogenesis and nutrient redirection to
the mammary gland. We reasoned that since XBP1 is regulated
by prolactin in adipocytes and is also involved in lipidmetabolism
in the liver (Deng et al., 2013; Lee et al., 2008; Wang et al., 2012),
it might be involved in the regulation of the adipocyte lipogenic














Figure 4. Adipocyte XBP1 Affects Milk Quantity and Lipogenic Gene Expression
Milk was collected from WT and XBP1DAd dams at d12L.
(A and B) Nonesterified fatty acid (NEFA) (A) and triglyceride (B) levels in milk.
(C) Heatmap of lipidomics analysis in XBP1DAd and WT milk.
(D and E) Lactose (D) and total protein (E) concentrations in WT and XBP1DAd milk.
(F) Milk quantitation assay. The amount of milk produced from each dam was measured as the difference in pup weight before and after a controlled 1.5 hr
feeding. Litters were pared to six pups. *p < 0.02 by standard t test.
(legend continued on next page)
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in adipocytes, we first overexpressed sXBP1, which resulted in
the expected upregulation of XBP1 target genes such as
Sec61 and Dnajc3, validating our experimental system (Fig-
ure 4H). Of note, sXBP1 expression in adipocytes resulted in a
broad downregulation of lipogenic/lipid-storing genes such as
Scd1, Fas, Acc, Dgat1/2, and Llp (Figure 4H). Next, we sup-
pressed Xbp1 expression in adipocytes through a viral small
hairpin RNA (shRNA) and examined the effect of prolactin on a
key lipogenic enzyme, stearyl CoA desaturase 1 (SCD1). Inter-
estingly, prolactin treatment caused an increase in SCD1 protein
expression in shXBP1 cells (Figures 4I and 4J). We also tested
these observations in vivo. Importantly, gonadal adipose tissue
from XBP1DAd dams during lactation showed higher levels of
FAS and SCD1 proteins (Figure 4K), consistent with the data
from prolactin-treated adipocytes in vitro. These data indicate
that XBP1 may be a critical factor in prolactin-mediated effects
on adipocytes given its regulation and requirement for suppress-
ing lipogenic genes in a prolactin-rich environment.DISCUSSION
The adipocyte is an extraordinary cell type that is poised to act at
the intersection of energy supply and demand. Although it can
harbor extreme lipid stores under conditions of energy surplus,
such as obesity, the adipocyte can also liberate these stores
dramatically when called upon by the demand of the organism,
such as during lactation. We were surprised to find that although
the UPR transcription factor XBP1 can influence in vitro differen-
tiation, adipocyte formation and function were not altered when
XBP1 was deleted in adipocytes in vivo, under either normal or
HFD conditions. Although obesity induces UPR activation in
adipose tissue, it may be that under metabolic stress, other
UPR branches compensate for the loss of XBP1, and this results
in little to no phenotype (Hotamisligil, 2010). Indeed, it is possible
that XBP1 plays a smaller role in the UPR response of the
obese adipocyte but has a distinct role in other processes that
demand extreme fluctuations of adipose depots and their
function. Supporting this claim, deletion of adipocyte XBP1
resulted in increased maternal adipose tissue, reduced milk
production, and reduced weight gain in XBP1DAd litters during
lactation. Furthermore, we showed that prolactin induces
XBP1 expression, and suggest that in response to prolactin,
XBP1 functions in adipocytes to maintain a low-level lipogenic
activity. We postulate that without XBP1, adipose tissue accu-
mulates lipid during lactation; milk production is then deprived
of this energy, and this results in less milk and therefore less
weight gain for the pups. Interestingly, poor lactation perfor-
mance is associated with increased adiposity or obesity in
women and also in cows (referred to as ‘‘fat cow syndrome’’;(G) Serum prolactin in NonPG and d10L WT and XBP1DAd mice.
(H) Heatmap of gene expression from F442A adipocytes overexpressing sXBP1
(I) qPCR demonstrating suppression of Xbp1 mRNA by adenoviral shRNA.
(J) Graph of densitometry data for protein levels of SCD1 in cultured adipocytes d
normalized to adiponectin. The basal WT SCD1 protein level was set at 1.
(K)Western blot analysis of FAS, SCD1, and Tubulin proteins in gonadal adipose ti
in the graph to the right.
All error bars indicate ±SEM. *p < 0.05, **p < 0.004 using standard t test; yp < 0.
CRasmussen, 2007). However, the biological mechanisms under-
lying these observations remain enigmatic.
Decreased pup weight resulting from a lactation defect has
been linked to low triglyceride levels or increased viscosity of
the milk making it difficult to release (Schwertfeger et al.,
2003; Zhu et al., 2005). Others have reported a similar compo-
sition but decreased volume of milk attributable to decreased
mammary gland lipogenic activity (Boxer et al., 2006; Rudolph
et al., 2010). We have not seen any alterations in milk compo-
sition or evidence of decreased lipogenic activity in the mam-
mary gland, but further investigation of these aspects may be
worthwhile. Therefore, we suggest that mammary gland func-
tion may be unchanged in XBP1DAd mice, and that signals
from adipose tissue are needed to maintain the level of produc-
tion of milk but not the gland’s developmental or functional
integrity. Interestingly, two hormonal signals, insulin and leptin,
are elevated in the serum of XBP1DAd dams during lactation
and these hormones are also increased in obese women.
Therefore, it would be worthwhile to investigate the effects of
the mother’s hormonal milieu on milk production. It is also
possible that other actions of XBP1, such as synthesis and
secretion of an unknown mediator to the mammary gland or
an immunological response, could be involved in the effect of
adipocyte function during lactation.
Thus, we suggest that this work introduces a new context in
which to study adipocyte function and biology, as well as UPR,
given that the majority of studies involving adipocytes have
focused on metabolic homeostasis. Here we reveal the adipo-
cyte’s influence on the directional or homeorhetic metabolism
of lactation. We anticipate that future studies will uncover
further essential adipocyte functions in this vital process of early
mammalian growth and survival.
EXPERIMENTAL PROCEDURES
Generation and Breeding of XBP1DAd Mice
C57BL/6 mice harboring loxP sites around exon 2 of XBP1 (Lee et al., 2008)
were crossed to mice carrying the Cre recombinase gene under aP2,
adiponectin, or LysM promoters (all three of the C57BL/6 genetic background).
A breeding strategy was followed to ensure that control (XBP1 flox/flox-noCre)
and experimental mice (XBP1flox/flox-Cre) were always littermates. Female
mice used for the pregnancy and lactation studies came from crosses of
flox/flox-no Cre females to flox/flox Cremales and were fed standard breeding
chow (Mouse Diet 20; PicoLabs). In all experiments, the numbers of pups
from WT and XBP1DAd litters were similar. The Institutional Animal Care and
Use Committee of the Harvard School of Public Health approved all of the
studies.
Laser-Capture Microdissection
Frozen mammary tissue sections (5 mm thick) from d1L were H&E stained
20 min prior to LCM. LCM was performed at the Specialized Histopathology
Core in the Dana-Farber/Harvard Cancer Center (Boston, MA, USA) usingor GFP control.
uring low or high (50–500 ng/ml) prolactin treatments. SCD1 protein levels were
ssue fromWT and XBP1DAdmice at d10L. Densitometry measures are provided
004 as measured by regular two-way ANOVA. See also Figure S4.
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the Arcturus PixCell II instrument along with Macro CapSure Caps (Molecular
Devices). For each animal, one slide of two serial sections was captured for
50–60 min with a laser beam size of 7.5 mm and power of 50 mW. RNA extrac-
tion of the isolated cells was performed using the PicoPure RNA Isolation kit
(Molecular Devices) and complementary DNA (cDNA) was synthesized from
the total RNA extracted (Fermentas). The levels of deleted (primers specific
to exon 2) and total (primers not in exon 2) Xbp1 mRNA were assessed by
quantitative RT-PCR (qRT-PCR).
Preparation of Mammary Gland Whole Mounts
Whole-mount preparations of mammary glands were performed according to
the protocol found on the NIH Biology of the Mammary Gland website (http://
mammary.nih.gov/tools/histological/Histology/index.html). Briefly, inguinal #4
mammary glands were dissected, spread on glass slides, and fixed overnight
in Carnoy’s fixative. The next day, the tissues were hydrated and then stained
in carmine-aluminum stain overnight. The tissues were dehydrated, cleared in
xylene, and mounted between two glass slides using Permount mounting
media.
Adipocyte Cell Culture
3T3L1 and F442A preadipocytes were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% bovine calf serum. To
induce differentiation, 3T3L1 cells were grown to confluence and fed induction
medium (DMEM, 10% cosmic calf serum [CCS], 5 mg/ml insulin, 0.5 mM
3-isobutyl-1-methylxanthine [IBMX], 1 mM dexamethasone, with or without
10 mM rosiglitazone). After 2 days, the medium was changed to DMEM,
10% CCS, and 5 mg/ml insulin. F442A cells were differentiated in only the
DMEM-CCS-insulin medium. Adipocytes were considered fully differentiated
at day 8.
CT Scan Imaging
Mice at d12L were anesthetized and scanned using the GE Explore CT 120
Micro-CT scanner. Data capture and reconstructions of the adipose tissue
were done using Osirix software.
Milk Collection and Analysis
Following overnight pup removal to facilitate milk accumulation, mice were
anesthetized at d12L. Milk was collected by gentle manual nipple stimulation.
Lactose was measured per kit instructions (Abcam) and total protein was
measured via the DC Protein Assay (Bio-Rad). Lipid extraction was done
on a 5 ml sample of milk, and triglyceride and free fatty acid content was
determined using Sigma and WAKO diagnostics assays, respectively.
In-depth lipidomics analysis was performed as described previously (Cao
et al., 2008) by Lipomics (Sacramento, CA).
Milk Quantitation
Quantitation of milk production was performed as previously described
(Jara-Almonte and White, 1972). In brief, 10-day-old pups were removed
from dams and fasted for 6 hr. The pups were then returned to the dams for
1.5 hr and litter weights were taken before (postfast) and after milking. The
difference in litter weight represents the amount of milk consumed.
For further details regarding the materials and methods used in this work,
see Extended Experimental Procedures.ACCESSION NUMBERS
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